E10.331
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
Type 1 diabetes mellitus is a chronic condition where the body's immune system attacks insulin-producing cells in the pancreas. This results in elevated blood sugar levels, which can lead to various complications over time. One such complication is diabetic retinopathy, a condition affecting the blood vessels in the retina of the eye. Specifically, ICD-10 code E10.331 refers to a form of diabetic retinopathy characterized by moderate nonproliferative changes accompanied by swelling in the central part of the retina, known as macular edema. This condition can impair vision and requires careful management to preserve eyesight.
Causes & Symptoms
Clinical Causes: Prolonged elevated blood glucose levels associated with poorly managed diabetes Chronic high blood pressure that damages retinal blood vessels High cholesterol levels contributing to blood vessel damage Duration of diabetes, typically longer periods increase the risk Genetic predisposition and family history of eye complications in diabetics
Key Symptoms: Blurred or distorted vision Dark spots or floaters in the visual field Difficulty seeing in low light conditions Sudden vision loss in some cases No noticeable symptoms in early stages, highlighting the importance of regular eye exams
Diagnostic & Treatment
Diagnosis Path: Diagnosing diabetic retinopathy involves a comprehensive eye examination, including dilated fundoscopy, where an ophthalmologist examines the retina for characteristic changes. Additional imaging tests, such as optical coherence tomography (OCT), can be used to detect and measure the extent of macular edema. Regular screening is essential for early detection and treatment before significant vision loss occurs.
Treatment Protocols: Management strategies focus on controlling blood sugar, blood pressure, and cholesterol to slow progression. Specific treatments for diabetic retinopathy with macular edema may include: - Laser therapy (focal or grid laser photocoagulation) to reduce fluid leakage and prevent further vision deterioration - Intravitreal injections of anti-VEGF (vascular endothelial growth factor) agents to decrease blood vessel growth and swelling - Corticosteroid injections or implants for reducing inflammation and edema - Monitoring and controlling risk factors through medication adjustments, diet, and lifestyle changes - Regular follow-up appointments to monitor eye health and treatment effectiveness
Clinical Advice & FAQs
Billing Guidance
Is E10.331 a billable ICD-10 code?
Yes, E10.331 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.331?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference